Treatment of Deep Vein Thrombosis in Pregnancy

Immediate Treatment Upon Diagnosis

The American College of Radiology recommends initiating therapeutic-dose low-molecular-weight heparin (LMWH) as soon as deep vein thrombosis (DVT) is confirmed on compression ultrasound, due to its superior efficacy and safety profile compared to unfractionated heparin 1, 2
LMWH is preferred over unfractionated heparin due to better efficacy, more predictable therapeutic levels, lower risk of heparin-induced thrombocytopenia, and reduced osteoporosis risk 2

The American College of Radiology suggests choosing one of the following weight-adjusted LMWH options: enoxaparin 1 mg/kg subcutaneously twice daily (preferred for acute DVT) or enoxaparin 1.5 mg/kg subcutaneously once daily (acceptable alternative) 1

Most pregnant women with low-risk acute DVT can be managed as outpatients, according to the American College of Radiology, but admission is recommended for those with hemodynamic instability, severe pain, extensive thrombosis, significant maternal comorbidities, or inadequate home support 1, 2, 3

The American College of Radiology recommends continuing therapeutic-dose LMWH throughout the entire pregnancy and for at least 6 weeks postpartum, with a minimum total treatment duration of 3 months, to minimize the risk of recurrent thrombosis 1, 2

The American College of Radiology advises against using vitamin K antagonists (warfarin/Coumadin) during pregnancy due to the risk of embryopathy and fetal bleeding, and recommends avoiding direct oral anticoagulants (DOACs) due to lacking safety data 1, 2

Routine monitoring of anti-factor Xa levels is not recommended unless there are specific concerns about achieving therapeutic levels, according to the American College of Radiology 1, 2

The American College of Radiology suggests planning for scheduled delivery with discontinuation of LMWH 24 hours before anticipated delivery, and resuming anticoagulation 8-12 hours after vaginal delivery or 12-24 hours after cesarean section if no significant bleeding is present 1, 2

The American College of Radiology recommends prescribing graduated compression stockings starting within 1 month of DVT diagnosis and continuing for at least 1 year to prevent postthrombotic syndrome, which occurs in up to 40% of pregnancy-related DVT cases 1, 2

For acute iliofemoral DVT with limb-threatening ischemia, the American College of Radiology suggests catheter-directed thrombolysis (CDT) or surgical thrombectomy with or without stent placement, but notes that catheter-directed thrombolysis is not recommended for routine DVT without limb threat 1, 3
The American College of Radiology recommends anticoagulation alone as the standard approach for acute iliofemoral DVT in pregnancy with moderate to severe symptoms, but suggests considering surgical thrombectomy in the second or third trimester to avoid radiation exposure 3, 4